PALEXIA SR tapentadol hydrochloride 25 mg sustained release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

palexia sr tapentadol hydrochloride 25 mg sustained release tablet blister pack

seqirus pty ltd - tapentadol hydrochloride, quantity: 29.12 mg (equivalent: tapentadol, qty 25 mg) - tablet, modified release - excipient ingredients: hypromellose; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate; purified talc; macrogol 6000; macrogol 400; titanium dioxide; iron oxide yellow; iron oxide red - palexia sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. palexia sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. palexia sr is not indicated as an as-needed (prn) analgesia.

APO-Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-rizatriptan rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: sucralose; magnesium stearate; mannitol; crospovidone; microcrystalline cellulose; flavour - rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT GH rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; aspartame; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT APOTEX rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt apotex rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; crospovidone; calcium silicate; colloidal anhydrous silica; magnesium stearate; mannitol; microcrystalline cellulose; flavour - rizatriptan odt is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-AU rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; calcium silicate; mannitol; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT GH rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; mannitol; microcrystalline cellulose; magnesium stearate; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

RIXALT rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rixalt rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; colloidal anhydrous silica; crospovidone; magnesium stearate; mannitol; microcrystalline cellulose; calcium silicate; flavour - rizalt is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; magnesium stearate; aspartame; mannitol; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.